Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

809
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
809
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

543
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
543

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of use of ambient listening technology on patient-reported communication and satisfaction ratings.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Perceived barriers to healthy eating and self-efficacy among Indian adults at high risk of type 2 diabetes: a secondary analysis of the K-DPP study.

Frontiers in nutrition·2026
Same author

Material economic hardships are associated with second-year hospitalizations after pediatric liver transplantation: Results from the SOCIAL-Tx study.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

The readiness of primary healthcare facilities to address non-communicable diseases in rural Bangladesh.

BMC health services research·2026
Same author

Identifying trajectories across care modalities before and after COVID-19 using sequence analysis.

NPJ digital medicine·2026
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026

Related Experiment Video

Updated: Jan 3, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

841

mHealth Interventions for Disadvantaged and Vulnerable People with Type 2 Diabetes.

Lindsay Satterwhite Mayberry1, Courtney R Lyles2, Brian Oldenburg3

  • 1Vanderbilt University Medical Center, Nashville, TN, USA.

Current Diabetes Reports
|November 27, 2019
PubMed
Summary

Digital interventions show promise for improving diabetes management (A1c) in vulnerable populations. While many studies report within-group improvements, more research is needed to confirm between-group benefits and optimize access for diverse individuals.

Keywords:
DisadvantagedDisparitiesHbA1cLifestyle interventionMobileTechnology interventionsType 2 diabetes

More Related Videos

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.2K

Related Experiment Videos

Last Updated: Jan 3, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

841
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.2K

Area of Science:

  • Digital Health
  • Diabetes Management
  • Health Disparities

Background:

  • Digital interventions are common for diabetes self-management and glycemic control.
  • Limited evidence exists on the acceptance and benefits for disadvantaged or vulnerable persons with diabetes.

Purpose of the Study:

  • To review studies on digital diabetes self-management interventions for disadvantaged/vulnerable adults with type 2 diabetes.
  • To evaluate the impact on glycemic control (hemoglobin A1c) and healthcare utilization.

Main Methods:

  • Systematic review of studies published from 2011-April 2019.
  • Included studies focused on disadvantaged/vulnerable populations (low socioeconomic status, racial/ethnic minority, rural, or LMIC).
  • Evaluated 21 digital interventions delivered via mobile or internet.

Main Results:

  • 16 of 21 studies reported within-group improvements in hemoglobin A1c.
  • Only 7 of 17 studies with control groups showed between-group differences in A1c.
  • Three studies indicated reductions in emergency room visits and hospitalizations.

Conclusions:

  • Digital interventions show potential for improving diabetes control and healthcare utilization in vulnerable groups.
  • Further research is required to validate findings and optimize intervention design, usability, and access.
  • Addressing issues like human support and economic value is crucial for maximizing impact.